Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2024-12-02 00:00:00 ET · period of report 2024-11-27 · accession 0001415889-24-027993 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-12-02 | 2024-11-27+ | KNSA | Megna Michael R | CAO | S - Sale+OE | $22.45 | -8,646 | 26.5K | -25% | -$194.1K |
| DM | 2024-12-02 | 2024-11-27+ | KNSA | Megna Michael R | CAO | M - OptEx | $11.10 | +8,646 | 35.2K | +33% | +$96.0K |
| DM | 2024-12-02 | 2024-11-27+ | KNSA | Megna Michael R | CAO | M - OptEx | $0.00 | -8,646 | 22.8K | -27% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Ordinary Share | 2024-11-29 | S | D | 9 | $22.45 | 26,528 | D | — | — | |
| 2 | Common | Class A Ordinary Share | 2024-11-29 | M | A | 9 | $11.10 | 26,537 | D | — | — | |
| 3 | Common | Class A Ordinary Share | 2024-11-27 | M | A | 8,637 | $11.10 | 35,165 | D | — | — | |
| 4 | Common | Class A Ordinary Share | 2024-11-27 | S | D | 8,637 | $22.45 | 26,528 | D | — | — | (F2) This transaction was executed in multiple trades through a broker-dealer at prices ranging between $22.45 and $22.465. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. |
| 5 | Derivative | Share Option | 2024-11-29 | M | D | 9 | $0.00 | 22,814 | D | $11.10 · — to 2032-04-06 | 9 Class A Ordinary Share | (F3) The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is April 7, 2022. |
| 6 | Derivative | Share Option | 2024-11-27 | M | D | 8,637 | $0.00 | 22,823 | D | $11.10 · — to 2032-04-06 | 8,637 Class A Ordinary Share | (F3) The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is April 7, 2022. |